骨形成蛋白6(BMP6)單克隆抗體
Monoclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
VGR; VGR1; Vegetal Related Growth Factor(TGFB-Related); VG-1-related protein
- 編號MAA646Hu23
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)D4
- Ig亞型 IgG2a Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原RPA646Hu01-骨形成蛋白6(BMP6)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度0.51mg/ml
- 且適物種-
- 應用WB
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 758¥ 1768¥ 2526¥ 6315¥ 25260
- 欲了解實際交易價格和更多情況，請與當?shù)亟涗N商聯(lián)系!
產品包裝(模擬)
產品包裝(模擬)
Western Blot; Samples: Lane1: 293T cell lysate; Lane2: MCF7 cell lysate; Primary Ab: 2μg/ml Mouse Anti-Human BMP6 Antibody Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對BMP6的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別BMP6。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunofluorescence:5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA646Hu01 | 骨形成蛋白6(BMP6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA646Hu01 | 骨形成蛋白6(BMP6)多克隆抗體 | WB; IHC |
| LAA646Hu81 | 骨形成蛋白6(BMP6)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| LAA646Hu71 | 骨形成蛋白6(BMP6)多克隆抗體(生物素標記) | WB |
| MAA646Hu22 | 骨形成蛋白6(BMP6)單克隆抗體 | WB; IHC |
| MAA646Hu21 | 骨形成蛋白6(BMP6)單克隆抗體 | WB |
| MAA646Hu23 | 骨形成蛋白6(BMP6)單克隆抗體 | WB |
| SEA646Hu | 骨形成蛋白6(BMP6)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA646Hu | 骨形成蛋白6(BMP6)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| International Journal of Cardiology | Valvular osteoclasts in calcification and aortic valve stenosis severity[PubMed: 23452891] |
| Polskie Archiwum Medycyny Wewn Trznej | New parameters in iron metabolism and functional iron deficiency in patients on maintenance hemodialysis[PubMed: 23111696] |
| PLoS ONE | A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches[Plosone: Source] |
| journal of biomedical materials research part b-applied biomaterials | In vitro chondrogenesis by BMP6 gene therapy[Pubmed: 23077084] |
| Journal of Clinical Pathology | Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C[PubMed: 26290259] |
| Clinical?and Experimental Pharmacology and Physiology | Bone morphogenetic protein 6—a possible new player in pathophysiology of heart failure[pubmed:27592865] |
| International Journal of Biological Macromolecules | SEQUENTIAL IGF-1 AND BMP-6 RELEASING CHITOSAN/ALGINATE/PLGA HYBRID SCAFFOLDS FOR PERIODONTAL REGENERATION[pubmed:28601648] |
| Elife | The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium[Pubmed:29749927] |